PMID- 32350175 OWN - NLM STAT- MEDLINE DCOM- 20210210 LR - 20210210 IS - 1881-7742 (Electronic) IS - 0301-4800 (Linking) VI - 66 IP - 2 DP - 2020 TI - Liver-Oriented Acute Metabolic Effects of A Low Dose of L-Carnitine under Fat-Mobilizing Conditions: Pilot Human Clinical Trial. PG - 136-149 LID - 10.3177/jnsv.66.136 [doi] AB - The acute metabolic effect of low dosages of L-carnitine under fat-mobilizing conditions was investigated. Healthy subjects (Study 1: n=5; Study 2: n=6) were asked to fast overnight. Then, 30 min of aerobic exercise on a cycle ergometer was performed after supplementation, followed by a 3.5-h sedentary recovery phase. The following ingestion patterns were used: Study 1 (i) noningestion, (ii) 750 mg of L-carnitine (LC), and (iii) 750 mg of LC+50 g of carbohydrate (CHO); Study 2 (iv) noningestion, (v) 500 mg of LC, (vi) 30 mg of CoQ(10), and (vii) 500 mg of LC+30 mg of CoQ(10). The energy expenditure (EE) and nonprotein respiratory quotient (npRQ) were measured during the pre-exercise, postexercise, and recovery periods. Serum free carnitine, acetylcarnitine, total carnitine (Study 1 and 2), and ketone bodies (Study 2) were measured. The 750 mg LC treatment significantly facilitated fat oxidation during the recovery phases (p<0.05) without elevating EE. The higher fat oxidation associated with LC was completely suppressed by CHO. CoQ(10) affected neither npRQ nor EE. npRQ was significantly correlated with the serum total ketone bodies (R=-0.68, p<0.001) and acetylcarnitine (R=-0.61--0.70, p<0.001). The highest correlation was found between acetylcarnitine and total ketone bodies immediately after exercise (R=0.85, p<0.001). In conclusion, LC enhanced liver fat utilization and ketogenesis in an acute manner without stimulating EE under fat-mobilizing conditions. FAU - Odo, Satoshi AU - Odo S AD - Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology. AD - Lonza Japan Ltd. FAU - Tanabe, Koji AU - Tanabe K AD - Lonza Japan Ltd. FAU - Yohda, Masafumi AU - Yohda M AD - Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology. FAU - Yamauchi, Masamitsu AU - Yamauchi M AD - Department of Management Nutrition, Aichi Gakusen University. LA - eng PT - Journal Article PT - Randomized Controlled Trial PL - Japan TA - J Nutr Sci Vitaminol (Tokyo) JT - Journal of nutritional science and vitaminology JID - 0402640 RN - 0 (Dietary Carbohydrates) RN - 0 (Ketone Bodies) RN - 1339-63-5 (Ubiquinone) RN - 6DH1W9VH8Q (Acetylcarnitine) RN - EJ27X76M46 (coenzyme Q10) RN - S7UI8SM58A (Carnitine) SB - IM MH - Acetylcarnitine/blood MH - Adipose Tissue/metabolism MH - Adult MH - Bicycling MH - Carnitine/administration & dosage/blood/*pharmacology MH - Dietary Carbohydrates MH - Double-Blind Method MH - *Energy Metabolism MH - Exercise/*physiology MH - Female MH - Humans MH - Ketone Bodies/*blood MH - Lipolysis/*drug effects MH - Liver/*drug effects/metabolism MH - Male MH - Muscle, Skeletal/metabolism MH - Oxidation-Reduction MH - Pilot Projects MH - Respiration MH - Ubiquinone/analogs & derivatives/pharmacology MH - Young Adult OTO - NOTNLM OT - L-carnitine OT - acetylcarnitine OT - acute effect OT - fat mobilization OT - healthy subjects OT - ketogenesis OT - ketone bodies OT - beta-oxidation EDAT- 2020/05/01 06:00 MHDA- 2021/02/11 06:00 CRDT- 2020/05/01 06:00 PHST- 2020/05/01 06:00 [entrez] PHST- 2020/05/01 06:00 [pubmed] PHST- 2021/02/11 06:00 [medline] AID - 10.3177/jnsv.66.136 [doi] PST - ppublish SO - J Nutr Sci Vitaminol (Tokyo). 2020;66(2):136-149. doi: 10.3177/jnsv.66.136.